ISRAEL CANCER RESEARCH FUND INC
ISRAEL CANCER RESEARCH FUND INC
ISRAEL CANCER RESEARCH FUND INC
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$20,966,521
Investments
77%
Cash & Equivalents
11%
Receivables (Non-Related)
8%
Other Assets
2%
Property, Plant, & Equipment (net)
<1%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$2,420,122
Grants Payable
73%
Other Liabilities
23%
Payables & Accruals
3%
Deferred Revenue
<1%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$5,600,057
$2,385,071
-57%
Receivables (Non-Related)
$2,204,696
$1,712,327
-22%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$64,769
$94,077
+45%
Investments
$10,640,998
$16,217,928
+52%
Property, Plant, & Equipment (net)
$185,978
$123,808
-33%
Other Assets
$555,621
$433,310
-22%
Total Assets
$19,252,119
$20,966,521
+9%
Liabilities
2023
2024
Change
Payables & Accruals
$127,141
$79,310
-38%
Grants Payable
$2,422,500
$1,775,000
-27%
Deferred Revenue
-
$15,288
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$735,223
$550,524
-25%
Total Liabilities
$3,284,864
$2,420,122
-26%
Net assets
2023
2024
Change
Restricted Net Assets
$8,451,885
$6,718,990
-21%
Unrestricted Net Assets
$7,515,370
$11,827,409
+57%
Net assets
2023
2024
Change
Net assets
+$15,967,255
+$18,546,399
+16%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)